Taiyen Biotech Co., Ltd. (TPE:1737)

Market Cap	6.39B
Revenue (ttm)	3.30B
Net Income (ttm)	352.67M
Shares Out	200.00M
EPS (ttm)	1.75
PE Ratio	18.26
Forward PE	n/a
Dividend	1.30 (4.07%)
Ex-Dividend Date	Aug 20, 2025

Volume	97,154
Average Volume	101,715
Open	32.00
Previous Close	31.95
Day's Range	31.90 - 32.00
52-Week Range	29.15 - 34.20
Beta	0.18
RSI	34.02
Earnings Date	Nov 7, 2025

About Taiyen Biotech

Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. Its products portfolio includes various salt and seawater chemical products; bath salt, bath salt milk, salt soap, algae soap, and shampoo; beverage and raw drinking water; skin care; toothpaste, salt mouthwash, and eye glass care solution; salt for washing fruits and vegetables; and food and food additives. The company also manufactures western medicine, environmental pharmaceuticals, and cosmetics. In addition, it imports and exports da...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1952
• Employees: 450
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1737

Financial Performance

In 2024, Taiyen Biotech's revenue was 3.24 billion, a decrease of -5.01% compared to the previous year's 3.41 billion. Earnings were 371.52 million, an increase of 23.68%.